Speaker illustration

Professor Wook-Jin Chung

Gachon University Gil Medical Center, Incheon (Korea (Republic of))

Member of:

European Society of Cardiology
Heart Failure Association

MD, Yonsei University Medical College (1988~1994) MS, Yonsei University (1996 - 1998) PhD, Yonsei University (2002 –2009) FACC (2016~Current) Member of ISHLT, ESC-HFA, ISH and ESH 2003 - Current Professor, Cardiology, Gachon University School of Medicine 2017 - Current Director, Gachon Cardiovascular Research Institute (GCRI) 2021 - Current Director, Planning and Coordination Office, Gachon University Gil Medical Center Chairperson, Scientific Committee, Korean Society of Heart Failure President, Korea Pulmonary Hypertension Society Editor-in-Chief, Clinical Hypertension 2011– 2012 Visiting Associate Professor, Stanford University School of Medicine 2008 – 2015 Vice Dean, Gachon University School of Medicine 2013 - 2016 Director, Department of Cardiology 2018 – 2021 Head, Department of Medical Care, Gachon University Gil Hospital 142 peer-reviewed articles (83 SCI(E) Journals, 44 First & Corresponding) 10 Books and 5 Patent Cases

Valsartan improves ventriculo-vascular coupling index dose-dependently in heart failure with reduced left ventricular ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment


Estimating the accuracy of common carotid artery intima-media thickness measurement using wireless and handheld ultrasounds

Event: EuroEcho-Imaging 2018

Topic: Imaging of Peripheral Vascular Disease

Session: Cross-Modality and Multi-Modality Imaging Topics


Korean team - A middle-aged man with progressive dyspnea despite of medical therapy

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Other

Session: HFA Championships


N-terminal pro-B type natriuretic peptide imply left ventricular diastolic function but is a low sensitivity marker

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods


This platform is supported by

logo Novo Nordisk